Eicosapentaenoic acid and arachidonic acid: collaboration and not antagonism is the key to biological understanding.

Horrobin, D F; Jenkins, K; Bennett, C N; Christie, W W

Horrobin, D F; Jenkins, K; Bennett, C N; Christie, W W.

Affiliation

Horrobin DF; Laxdale Ltd, King Park House, LaurelhiIl Business Park, Stirling FK7 9JQ, Scotland. agreen@laxdale.co.uk

Prostaglandins Leukot Essent Fatty Acids ; 66(1): 83-90, 2002 Jan.

Article in En | MEDLINE | ID: mdl-12051959

Subject(s)

Arachidonic Acid/analysis; Dietary Fats/pharmacology; Eicosapentaenoic Acid/administration & dosage; Eicosapentaenoic Acid/pharmacology; Erythrocyte Membrane/drug effects; Animals; Arachidonic Acid/blood; Dietary Fats/administration & dosage; Dietary Fats/analysis; Dietary Fats/therapeutic use; Dose-Response Relationship, Drug; Eicosapentaenoic Acid/analysis; Eicosapentaenoic Acid/therapeutic use; Erythrocyte Membrane/metabolism; Fatty Acids, Omega-6; Fatty Acids, Unsaturated/pharmacology; Female; Humans; Rats; Rats, Wistar; Schizophrenia/blood; Schizophrenia/drug therapy; Schizophrenia/metabolism

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Dietary Fats / Eicosapentaenoic Acid / Arachidonic Acid / Erythrocyte Membrane Type of study: Clinical_trials Limits: Animals / Female / Humans Language: En Journal: Prostaglandins Leukot Essent Fatty Acids Year: 2002 Document type: Article

Search on Google

XML

PubMed Links